The COVID-19 vaccine targeting the original strain of the virus as well as two substrains of the omicron variant will now be used for all vaccinations in the U.S., federal regulators said Tuesday. The bivalent vaccine has, until Tuesday's changes to the emergency use authorizations for the Moderna and Pfizer-BioNTech vaccines, only been approved for use as a booster vaccine.

The post All COVID Vaccinations to be Bivalent Vaccine to ‘Simplify’ Recommendations, FDA Says first appeared on Post News Group.